The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin - Wikidata - awgldk - TriplyDB

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

http://www.wikidata.org/entity/Q28218417

about

sameAs

Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations Platelet hyperreactivity: predictive and intrinsic properties Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence.Antiplatelet therapy: aspirin resistance and all that jazz!Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.

P2860

Q28195907-95343AE2-1035-4266-8345-05EC485BCCF1 Q28221437-2E80CFB9-A41A-4CE4-A930-A9BAF27A48F3 Q35788838-7C05387F-EBE1-4E5B-8B77-BC29C3EB5DB9 Q36002765-108227DA-CB3C-4702-BC7A-4FA133BE1C2B Q37608580-64429159-9A27-427C-B126-D82E6FDBDAA8 Q38023196-90B88B08-FD60-417B-B442-C3315D32C1D3 Q42667008-64D7BFEC-529E-48FB-8C2C-8B5F3433D76B

P2860

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

http://www.wikidata.org/entity/Q28218417

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@ast

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@en

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@nl

type

label

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@ast

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@en

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@nl

prefLabel

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@ast

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@en

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@nl

P1433

Q28218417-578A934C-ACD8-45E5-9B3E-321F854F21EB

P1476

Q28218417-D1713EE0-EC22-4EDB-804A-E617773C847F

P2093

Q28218417-123DD572-81B6-4272-B8E3-9FCD205B1C95

Q28218417-38B9133F-246A-4730-ACA8-E70D4B9CF5DA

Q28218417-88E07789-0BC4-4183-8FEB-54E46061D335

Q28218417-CBFA576F-93AA-4A80-BFCC-7B7CA64A3482

Q28218417-D2302B24-6350-43A3-8F6C-D86AA3169EF2

Q28218417-EA8C79D3-2D5A-46B9-9E77-0313FEF8ECAD

P2860

Q28218417-0B895C89-3101-48DA-9A38-6B10894D1274

Q28218417-139E77B0-22FB-4348-AE53-FFEEC4BCDD9B

Q28218417-1D4D3029-2A17-4240-B38C-B7B1F620FB55

Q28218417-1ECB035F-6533-4A20-AD11-D06E9D8D2DA0

Q28218417-22DCA9CD-9CC3-41D5-A134-AE4F766560A4

Q28218417-26B4ECE6-3E88-46B8-951A-7D2DAA22E4CD

Q28218417-83AC5B0C-0E39-45F5-9BF1-48D5E6465071

Q28218417-A19F4F95-67FC-4EE2-906E-C99852D114C5

Q28218417-A2EB1EC4-54EE-46AF-80AF-025B97F4947A

Q28218417-B92A5A90-9EB5-4567-A72A-7CF544977A3A

P304

Q28218417-35275613-F5C9-456B-A26A-1DDC4678AD1B

P31

Q28218417-692110A6-A4E9-42B1-AB9C-5A2A4A5043A8

P356

Q28218417-C1F72844-B90A-455C-B491-4CE7A95AE8BD

P407

Q28218417-D53EED3A-86B3-4523-910A-119CF3B1B63F

P433

Q28218417-AFC19696-F122-4DB0-AA79-551CC19AD74F

P478

Q28218417-A324C8A9-53A7-424B-8D8F-24B38C14BBE7

P50

Q28218417-1394BC2E-253D-4E2B-9661-5EA18FAFE53B

Q28218417-96E070F2-F0E4-485D-89E0-D9878E882E55

P577

Q28218417-CA20C14C-191A-4A91-80D6-F214DF0F9752

P698

Q28218417-19D1685A-6091-46A1-BFA1-7064F1DCB9AD

P921

Q28218417-808B3A10-AA6D-45B2-A1DA-46A51326F527

P356

69537100412351272550

P1433

P1476

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

@en

P2093

A Sambola

http://www.w3.org/2001/XMLSchema#string

G Sanz

http://www.w3.org/2001/XMLSchema#string

M Heras

http://www.w3.org/2001/XMLSchema#string

M Pino

http://www.w3.org/2001/XMLSchema#string

M Torra

http://www.w3.org/2001/XMLSchema#string

T Martorell

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial)

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

Clinical utility of available methods for determining platelet function.

The use of aspirin in ischemic heart disease.

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.

Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers

P304

439-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/69537100412351272550

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15745315

http://www.w3.org/2001/XMLSchema#string

P921